Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TAKAMORI, M.
Right arrow Articles by IWANAGA, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TAKAMORI, M.
Right arrow Articles by IWANAGA, S.
NEUROLOGY 1976;26:844
© 1976 American Academy of Neurology

Experimental myasthenia due to alpha-bungarotoxin

MASAHARU TAKAMORI, M.D. and SADAAKI IWANAGA, Ph.D.

From the First Department of Internal Medicine, Nagasaki University School of Medicine, and the Institute for Protein Research, Osaka University.

Neuromuscular transmission was studied electrophysiologically in rabbits intoxicated by {alpha}-bungarotoxin, a specific inhibitor of acetylcholine receptor. The findings consisted of a slight reduction in amplitude of single evoked muscle action potential, a decrement in amplitude of successive evoked muscle action potentials, post-tetanic potentiation and exhaustion, edrophonium reversal, and no change of muscle action potentials evoked by direct stimulation of the muscle. These were similar to characteristic electrophysiologic phenomena seen in 40 patients with myasthenia gravis. The receptor abnormality may be responsible for the underlying defect of myasthenia.

Requests for reprints should be addressed to Dr. Takamori, First Department of Internal Medicine, Nagasaki University School of Medicine, 7-1, Sakamoto-machi, Nagasaki, Japan.

This investigation was supported in part by the Myasthenia Gravis Research Grant funded by the Japanese Ministry of Health and Welfare (Dr. Takamori).

Received for publication October 27, 1975.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by AAN Enterprises, Inc.